Skip to main content
Clinical Trials/CTRI/2021/01/030799
CTRI/2021/01/030799
Completed
未知

An Observational study to assess the clinical significance of Adipokines in patients with Non-Hodgkin�s Lymphoma

JAMIA HAMDARD0 sites62 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: C858- Other specified types of non-Hodgkin lymphoma
Sponsor
JAMIA HAMDARD
Enrollment
62
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
June 10, 2021
Last Updated
3 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Patient who are 18\-65 years old
  • 2\.Patients who were diagnosed with B \-cell NHL either by pathology or cytology (only newly diagnosed)
  • 3\.Both genders.
  • 4\.Patient capable of giving informed consent
  • 5\.Patient willing to participate in the study
  • 6\.Patients having Body Mass Index (BMI) less than 30
  • 7\.Patient capable of understanding either Hindi or English
  • 7\.Patient capable of understanding either Hindi or English

Exclusion Criteria

  • ââ?¬Â¢Exclusion Criteria: \-
  • 1\.Patients having a history of cognitive impairment and Alzheimerââ?¬•s disease.
  • 2\.Patients having a history of head injury, organ failure and organ transplant
  • 3\.Patients having any secondary cancer
  • 4\.Patients having neuropsychiatric disorders, neurological and neurobehavioral diseases
  • 5\.Patients on any psychotropic medications
  • 6\.Patients having a history of drug and alcohol abuse
  • 7\.Patients using any concurrent medication like cholinergic drugs, antidepressants, anti\-inflammatory drugs or analgesics
  • 8\.Lactating or pregnant patients
  • 9\.Patients not taking adequate contraception

Outcomes

Primary Outcomes

Not specified

Similar Trials